DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 2 Biden - 2 Jamie Dimon - 1 Jeremy Barnum - 1 Barnum - 1 that's - 1 Goldman Sachs - 1 Stephan Feldgoise - 1
Top related locs:
megamergers dealmaking Asia Pacific Berkshire Lactalis Cigna Aetna
Top related orgs:
Service - 2 Justice Department - 2 JPMorgan - 1 Business - 1 London Stock Exchange Group - 1 3G - 1 CNBC - 1 Kraft - 1

Search resuls for: "megamergers"


8 mentions found


☆ Here's why JPMorgan's top brass are doubtful that a major M&A comeback is on the horizon
  + stars: | 2024-04-12 | by ( Reed Alexander | ) www.businessinsider.com   time to read: +5 min
download the appSign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read previewWall Street has been hopeful that M&A activity will return this year as rates fall. On Friday, the bank reported $41.9 billion in revenue for the quarter, up 9% year-over-year — a figure that surpassed analysts' expectations. The retreat from dealmaking produced a nine-year low in terms of the number of individual M&A transactions in the quarter, LSEG reported. Dimon's warningsThe comments from JPMorgan's top brass come as Dimon issues warnings about the prospect of a gloomier economic environment.
Persons: —, Jamie Dimon, Jeremy Barnum, Barnum, Biden, that's, Goldman Sachs, Stephan Feldgoise, LSEG, EY, Dimon, Reed Alexander Organizations: Service, JPMorgan, Business, London Stock Exchange Group Locations: megamergers, dealmaking, Asia, Pacific
☆ 3G Capital quietly exited its Kraft Heinz investment last year
  + stars: | 2024-04-09 | by ( Amelia Lucas | ) www.cnbc.com   time to read: +3 min
They had continued to be an investor and were treated as we do any investor," Kraft Heinz said in a statement to CNBC. "We did learn from their recent filing that 3G exited the Kraft Heinz stock entirely in 2023." Brazilian private equity firm 3G Capital quietly sold off its 16.1% stake in Kraft Heinz in the fourth quarter, nearly nine years after masterminding the blockbuster merger of Kraft Foods and Heinz with Warren Buffett. Kraft Heinz sought to drive inorganic growth through a takeover bid for Unilever, but the Popsicle owner rejected its offer. In 2022, it distributed about 7% of Kraft Heinz to investors in its fund, which reportedly included tennis star Roger Federer.
Persons: Kraft Heinz, Warren Buffett, 3G's, Heinz, Buffett, Jorge Paulo Lemann, Alexandre Behring, Joao Castro, Neves, Roger Federer, Carlos Abrams, Rivera, he's Organizations: 3G, CNBC, Kraft, 3G Capital, Kraft Foods, Heinz, Busch InBev, Burger King, Big, Unilever, Securities and Exchange, Berkshire, InBev, Planters Locations: Berkshire, Lactalis
☆ Why a giant health insurer merger is probably destined to fail
  + stars: | 2023-11-30 | by ( ) www.businessinsider.com   time to read: +7 min
The giant health insurers Cigna and Humana are reportedly considering a merger. While they offer different kinds of health insurance, the deal is likely to face antitrust scrutiny. Still, Cigna and Humana did toy with a deal way back in 2014 before they pursued deals with other partners. Later, to sidestep antitrust scrutiny, health insurers eyed mergers with other pieces of the healthcare system outside of insurance. Cigna and Humana would face a more skeptical Justice DepartmentAny deal between health insurers the size of Cigna and Humana would have to get past the Justice Department's antitrust enforcers.
Persons: Biden, —, Justice that's, BofA, David Balto, Cigna, That's, Balto, Barak Richman, there's, Matthew Cantor, Constantine Cannon, divestitures aren't, Molina wouldn't, Cantor Organizations: Humana, Service, Reuters, Bloomberg, Street, Department, Justice, Cigna, UnitedHealth Group, Equity, Federal Trade Commission, Justice Department, Express, CVS Health, Aetna, Kindred, Biden Administration, FTC, Duke University Locations: Cigna, Aetna, Delaware
☆ JetBlue sinks to 12-year low as airline forecasts more losses, Spirit antitrust trial begins
  + stars: | 2023-10-31 | by ( Leslie Josephs | ) www.cnbc.com   time to read: +1 min
JetBlue Airways stock tumbled to a nearly 12-year low Tuesday as the company forecast a loss for the fourth quarter and heads to court to defend its acquisition of budget carrier Spirit Airlines , a purchase it argues is crucial to its future. Shares fell more than 18% in early trading Tuesday to $3.42 apiece before recovering some of those losses. Spirit shares fell more than 17% at their lowest point to a three-year low. JetBlue plans to remove seats from Spirit's bright-yellow planes and outfit them with seatback screens to match JetBlue's interiors. Spirit's business model is based on packed planes, no-frills fares and fees for everything from seat assignments to carry-on luggage, while JetBlue has more amenities and fewer seats on board.
Organizations: JetBlue Airways, Spirit Airlines, U.S . Department of Justice, Frontier Airlines, U.S, JetBlue, Southwest, Justice Department Locations: Delta, United, U.S
☆ Chevron and Exxon's latest buys could usher in a new era of oil megamergers
  + stars: | 2023-10-27 | by ( Lee Ying Shan | ) www.cnbc.com   time to read: +1 min
Energy heavyweights Chevron and Exxon Mobil announced shiny new acquisitions this month — and some industry watchers say it could be the start of more multibillion megadeals to come. Chevron on Monday said it's buying Hess for $53 billion in stock, allowing Chevron to take a 30% stake in Guyana's Stabroek Block — estimated to hold some 11 billion barrels of oil. The announcement comes just weeks after Exxon Mobil announced its purchase of shale rival Pioneer Natural Resources for $59.5 billion in an all-stock deal. While this marks Exxon's largest deal since its acquisition of Mobil, the merger would also double the oil giant's production volume in the largest U.S. oilfield, the Permian Basin. "The big-money acquisition of Hess by Chevron accelerates the trend of consolidation and big-money deals," energy consultancy Rystad Energy said in a note.
Persons: it's, Hess Organizations: Energy, Chevron, Exxon Mobil, Natural Resources, Mobil, Hess, Rystad Energy, Exxon, Pioneer Locations: Guyana
☆ When Megamergers Fall Apart
  + stars: | 2023-04-26 | by ( Lazaro Gamio | Lauren Hirsch | ) www.nytimes.com   time to read: +1 min
Lazaro Gamio andBritish antitrust regulators on Wednesday blocked Microsoft’s $69 billion bid to buy the gaming giant Activision Blizzard, threatening to kill the deal entirely. The ruling raises a broader question: How often do deals fall apart after they’re signed? So far this year, just 33 out of 3,347 bids to buy an American company have been withdrawn. In 2022, nearly 12,000 such deals were announced, totaling $170 billion, and 142 were withdrawn. A transaction can fall apart for any number of reasons, but when regulators step in to stop a merger, it’s generally because they have concerns the deal would have a detrimental effect on consumers, or the country at large.
☆ Bayer's new CEO has a full in-tray as investors push for change
  + stars: | 2023-02-09 | by ( ) www.reuters.com   time to read: +5 min
February 9 - By Ludwig Burger and Patricia WeissFRANKFURT (Reuters) - Bayer's incoming CEO is inheriting a full in-tray from his predecessor: Thousands of lawsuits claiming its weedkiller causes cancer, an underwhelming drug development pipeline and disgruntled investors looking for major change. "The most important task for Bill Anderson is to regain investors' trust," said Markus Manns, a portfolio manager at Germany's Union Investment, a top 20 shareholder. Bayer's shares lag those of its global rivals, having fallen about 40% - knocking about 30 billion euros off its market valuation - since it bought Monsanto in 2018 for about $63 billion. Baumann's early exit has stirred debate about what the 56-year-old Anderson can do to restore investor trust and boost Bayer's shares. A stand-alone pharmaceuticals business, with 18.3 billion euros in 2021 sales, could also become a takeover target.
☆ Health-care stocks are looking good for 2023 and not just because the sector is a 'safe haven'
  + stars: | 2022-12-21 | by ( Christina Cheddar Berk | ) www.cnbc.com   time to read: +9 min
Investors looking for cover this year would have done well if they sought a safe haven in large-cap pharmaceutical stocks, a trend that is likely to continue into 2023. The Inflation Reduction Act provided some clarity around drug pricing that should help health-care stocks. The average price target, according to FactSet, is $62, or nearly 40% above the stock's closing price on Tuesday. Gene therapies in focus Investors will be closely watching the progress of several gene therapies, according to Phipps. "Yes, these are expensive therapies," Phipps said.
0 next >>
Total: 8